Pembrolizumab in Combination With Radiotherapy in Locally Advanced Non-Small Cell Lung Cancer (NSCLC)

NCT03245177 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Funding withdrawn.

Conditions

Non Small Cell Lung Cancer

Interventions

BIOLOGICAL: Pembrolizumab
RADIATION: Radiotherapy

Sponsor

Prof Corinne Faivre-Finn

Collaborators

[object Object]
[object Object]
[object Object]